Please set your pop-up blockers to allow pop-ups on www.peerviewpress.com. We use pop-ups to display content. Click Help for more information.

FEATURED PRESENTATION

Simplifying the Treatment of CLL

Interviewee
Laurie H. Sehn, MDCM, MPH

Interview is based on data presented at the 51st Annual Meeting of the American Society of Hematology, December 5-8, 2009, New Orleans, Louisiana*

*PeerView Press is an independent publisher of conference news and medical education programmes.
The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView Press or any of its supporters.

2010-03-22
Audio - CLL Therapy: What Is the Best Option for Your Patient?
Laurie H. Sehn, MDCM, MPH
University of British Columbia
Vancouver, British Columbia Download this Presentation's Materials
Slides
Printable Transcript
MP3
Publication - InCongress article 2009-12-06 Benefits of Imatinib in Patients With Chronic Myeloid Leukaemia Extend to 8 Years: Presented at ASH

Publication - InCongress article 2009-12-06 Single-Agent Pixantrone Effective for Patients With Relapsed/Refractory Non-Hodgkin's Lymphoma: Presented at ASH

Publication - InCongress article 2009-12-06 Aspirin and Nadroparin No Better Than Placebo Among Women With History of Unexplained Miscarriage: Presented at ASH

Publication - InCongress article 2009-12-07 Investigational Omacetaxine Appears to Overcome Tyrosine Kinase-Resistant Chronic Myeloid Leukaemia: Presented at ASH

Publication - InCongress article 2009-12-07 Extending Rivaroxaban Prophylaxis Significantly Reduces Risk of Venous Thromboembolic Events: Presented at ASH

Publication - InCongress article 2009-12-07 Investigational Oral Agent Reduces Symptoms in Patients With Myelofibrosis: Presented at ASH

Publication - InCongress article 2009-12-07 Neutropenia Not a Barrier to Long-Term Lenalidomide/Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma: Presented at ASH

Publication - InCongress article 2009-12-07 Melphalan Better Partner With Bortezomib for Older Patients With Untreated Multiple Myeloma: Presented at ASH

Publication - InCongress article 2009-12-07 Aprepitant Reduces Nausea, Vomiting Associated With Emetogenic Preparative Regimens Prior to HSCT: Presented at ASH

Publication - InCongress article 2009-12-08 Increased Severity of H1N1 in Children and Adults With Sickle Cell Disease: Presented at ASH

Publication - InCongress article 2009-12-08 Cardiac Function Continues to Improve in Beta-Thalassemia Patients After 2 Years on Iron Chelation With Deferasirox: Presented at ASH

Publication - InCongress article 2009-12-08 Nilotinib Appears Superior to Imatinib in Newly Diagnosed Chronic Myeloid Leukaemia Patients: Presented at ASH

Publication - InCongress article 2009-12-08 Intravenous Iron Not Superior to Oral Iron in Chemotherapy-Associated Anaemia Treated With Darbepoetin Alfa: Presented at ASH

Publication - InCongress article 2009-12-09 Deferasirox Reduces Iron Burden in Patients With Beta-Thalassaemia: Presented at ASH

Publication - InCongress article 2009-12-09 Patients With Indolent Lymphomas Exhibit Long-Term Survival With Tositumomab After Rituximab Failure: Presented at ASH

Publication - InCongress article 2009-12-09 Patients With Chronic Myeloid Leukaemia Achieve Strong Response With Early Dasatinib Treatment: Presented at ASH

Publication - InCongress article 2009-12-09 Impact of Bortezomib on Survival in Previously Untreated MM Extends to 3 Years: Presented at ASH

Publication - InCongress article 2009-12-09 Lenalidomide Combination Therapy Improves Progression-Free Survival in Elderly Multiple Myeloma Patients: Presented at ASH

Publication - InCongress article 2009-12-10 Oral Mucositis More Frequent in Obese Patients With Multiple Myeloma on Melphalan Therapy: Presented at ASH

Publication - InCongress article 2009-12-10 Deferasirox Monotherapy Improves Cardiac Iron Burden in Patients With Beta-Thalassaemia: Presented at ASH

Publication - InCongress article 2009-12-10 Once-Daily Enoxaparin Feasible in Some Children at Risk of Venous Thromboembolism: Presented at ASH

Publication - InCongress article 2009-12-10 Low-Molecular-Weight Heparin Reduces Risk of Venous Clots in Patients With Pancreatic Cancer: Presented at ASH

Publication - InCongress article 2009-12-10 Skin Cancers Observed More Frequently in Patients With CLL Than in General Population: Presented at ASH